New York, NY -- LexisNexis Legal & Professional today released results from an independent study of 5,061 U.S. law students that shows Lexis Advance is preferred over Westlaw for legal research. The survey of law students at 201 ABA-accredited U.S. law schools was conducted to better understand future lawyer attitudes, behaviors, and key drivers of user preference in relation to legal research.

Raleigh, NC -- The need for organizations to mitigate an evolving array of third-party reputational, regulatory, financial and strategic business risks, has driven an innovative partnership between Blue Prism (AIM: PRSM) and  Nexis® Solutions. The partnership will see Blue Prism’s connected-RPA platform integrated with Nexis Diligence™, in order to help organizations improve the efficiency and effectiveness of their entity due diligence process with intelligent automation capabilities.

Menlo Park, CA — Lex Machina, a LexisNexis company, today announced the 10-year anniversary of the introduction of Legal Analytics® to the commercial legal market. Originally a public interest project at Stanford University, Lex Machina created a groundbreaking technology that has indelibly changed both the business and practice of law. Lex Machina is now the de-facto standard for legal analytics, and its award-winning technology is used by major corporations, such as Eli Lilly, Facebook, Microsoft, Nike, Luxottica, Uber,  and SAP; litigation finance firms like Burford and Bentham IMF; and 74% of the Am Law 100 with firms such as White & Case, Ropes & Gray, Ogletree Deakins, Jackson Lewis, Wilson Sonsini, as well as many boutique law firms.

New York, N.Y. — Knowable, a Contracts Data Management company and the world’s largest translator of contracts language into structured data, today announced the launch of its new platform. Knowable’s intuitive platform for finding and accessing contract information helps organizations turn their contracts into consumable data and practical insights that support better business decisions, and a more modern approach to risk management. 

NEW YORK – LexisNexis® Legal & Professional, a leading global provider of information and analytics, today announced two free resources from Law360® and Lexis Practice Advisor® to help legal professionals, lawmakers and business leaders become better informed and successfully navigate the legal issues and intricacies surrounding the Novel Coronavirus (COVID-19).

RALEIGH – Juris, a premier billing, accounting, and financial management software for law firms, has officially endorsed ClientPay®, an award-winning cloud-based credit card and eCheck payment platform as the premier choice for Juris users. Law firms can now provide their clients with the capabilities to pay their invoices in less time, without mailing checks or picking up the phone. ClientPay® is equipped to allow users to tailor a payment solution for their A/R department that can save time and money. On average, firms that switch to ClientPay® save 17% on processing fees and spend 50% less time on payment management. Firms get paid faster and staff are freed from the burden of manual payment processing.

Cambridge, Massachusetts : The MIT Press, [2019]

Montreal ; Kingston ; London ; Chicago : McGill-Queen's University Press ; Winnipeg : Mentoring Artists for Women's Art, 2017

Montreal [Que.] : McGill-Queen's University Press, ©2006 (Saint-Lazare, Quebec : Canadian Electronic Library, 2010)

"We are confident that, under the Make in India programme, factors affecting competitiveness will be removed," Kenichi Ayukawa, MD, Maruti Suzuki India.

The company will also phase out Classic' entry sedan to make way for the new mid-size car that was showcased at the Delhi Motor Show in February this year.

Pareek comes with over two decades of experience with Maruti Suzuki where his last role was as COO, wherein he was heading Marketing & Sales vertical.

Hybrid material could aid protein structure determination and drug delivery

The startup raised $40 million to target a class of GPCRs called Mas-related G-protein receptors, to treat neuroimmune and inflammatory conditions

Catalyst spurs insoluble salts into action as nucleophiles for enantioselective reactions

El profesor de Química y bloguero de Compound Interest Andy Brunning explica los parecidos y las diferencias entre ambos productos de baño.

At the third meeting of GP-write, researchers decide to create virus-resistant human cells

Joined by CRISPR luminaries Feng Zhang and J. Keith Joung, the Harvard chemist raises up to $87 million in funding

With $45 billion investment, national oil firm seeks diversification away from oil and gas

The start-up, based on the work of Broad Institute scientist Aviv Regev, has raised $65 million to develop therapies for cancer and autoimmune disease

Stretchable strain and pressure sensor might one day guide rehabilitation

In cells, inhibitor created by fragment-based drug design prevents rhinovirus from reproducing

With $40 million series A funding, the start-up will develop inhibitors of proteins that make chemical modifications to RNA

On the brink of patient trials, genome-editing heavyweights and regulators meet to set up voluntary standards

Joined by CRISPR luminaries Feng Zhang and J. Keith Joung, the Harvard chemist raises up to $87 million in funding

Big investments are planned in Abu Dhabi, Qatar, and Algeria to diversify away from oil and gas

Agency plans legal limit on four PFASs in drinking water, creating liability for PFOS and PFOA contamination

Creams. Wax. Sugar. Lasers. We get to the scientific root of depilation

The start-up wants to develop treatments based on two kinds of bacteria linked to the antiseizure effects of the ketogenic diet

Chemists use the reaction to develop a greener route to epilepsy drug

The start-up wants to develop treatments based on two kinds of bacteria linked to the antiseizure effects of the ketogenic diet